FDA fast-tracks review of overdose drug naloxone for use without prescription
2 min read . Updated: 27 Dec 2022, 06:51 PM IST
Premium- Nonprofit Harm Reduction Therapeutics plans to distribute doses cheaply and free
A pharmaceutical nonprofit was granted priority review from the Food and Drug Administration to make an inexpensive overdose-reversal drug for use without a prescription.
×![]()
